Skip to content

Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women

Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06409052
Enrollment
45
Registered
2024-05-10
Start date
2024-06-25
Completion date
2030-08-30
Last updated
2026-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Cancer

Brief summary

To learn more about women's attitudes toward and knowledge about endometrial cancer and options that might decrease the risk of developing

Detailed description

To obtain pilot data regarding women's attitudes and perspectives about endometrial cancer and potential endometrial cancer prevention strategies.

Interventions

BEHAVIORALQualitative interviews

Interviews will be conducted for approximately 45-60 minutes

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum

Inclusion criteria

1. Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of endometrial cancer 2. Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of abnormal uterine bleeding or endometrial hyperplasia 3. Women without a diagnosis of endometrial cancer or endometrial hyperplasia 4. Women must be at least 18 years or age 5. Women must be able to read, write, and speak English 6. Women must be willing and able to provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Patient educationThrough study completion; an average of 1 year.To build a patient tool for educating and empowering women to make informed decisions about endometrial cancer prevention strategies.

Countries

United States

Contacts

CONTACTLarissa Meyer, MD
lmeyer@mdanderson.org(713) 745-0973
PRINCIPAL_INVESTIGATORLarissa Meyer, MD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 17, 2026